Clinical Trial Update: Assessment of Lesion Activity Analysis in the Avonex- Steroid Azathioprine (ASA) Study

View source ↗

Summary

This completed clinical trial update reports on a study assessing lesion activity in relapsing-remitting multiple sclerosis patients treated with Avonex in comb…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis Relapsing-remitting

Drugs mentioned

• Avonex (Interferon beta-1a)
• Azathioprine (azathioprine)

Snippet

Sponsor: University at Buffalo | Conditions: Multiple Sclerosis, Relapsing-remitting | Status: COMPLETED